|
Volumn 44, Issue 11, 2006, Pages 742-744
|
Prevention and treatment of hepatitis B virus reinfection after liver transplantation
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIVIRUS AGENT;
HEPATITIS B SURFACE ANTIGEN;
HEPATITIS B(E) ANTIGEN;
LAMIVUDINE;
ARTICLE;
BLOOD;
FEMALE;
FOLLOW UP;
HEPATITIS B;
HUMAN;
IMMUNOLOGY;
LIVER TRANSPLANTATION;
MALE;
MULTIMODALITY CANCER THERAPY;
PASSIVE IMMUNIZATION;
PROSPECTIVE STUDY;
RECURRENT DISEASE;
RISK FACTOR;
TIME;
ANTIVIRAL AGENTS;
COMBINED MODALITY THERAPY;
FEMALE;
FOLLOW-UP STUDIES;
HEPATITIS B;
HEPATITIS B E ANTIGENS;
HEPATITIS B SURFACE ANTIGENS;
HUMANS;
IMMUNIZATION, PASSIVE;
LAMIVUDINE;
LIVER TRANSPLANTATION;
MALE;
PROSPECTIVE STUDIES;
RECURRENCE;
RISK FACTORS;
TIME FACTORS;
|
EID: 34347215293
PISSN: 05295815
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (3)
|
References (0)
|